“…Protein particles, consisting of aggregated protein and possibly a nonprotein nucleating core, can form in biopharmaceutical drugs . Stresses that can lead to the formation of protein particles include changes in chemical environment, exposure to interfaces, agitation, elevation of temperature, or the introduction of nonprotein particles . Counting and characterizing these particles is necessary to assure the quality of these drugs.…”